拢25m backing for MedTech Prokarium
Prokarium, a biopharmaceutical company leading the oncology field of microbial immunotherapy, has raised 拢25 million in new funding.聽 Prokarium鈥檚 lead programme has the potential to transform the treatment paradigm in bladder cancer, one of the costliest cancers to treat. The firm says this area has seen little innovation in over 30 years. Prokarium鈥檚 pipeline leverages … Continue reading 拢25m backing for MedTech Prokarium
